ThermImage

December 4, 2008 (Salt Lake City, Utah) – Thermimage Inc is pleased to announce the addition of Phil Eggers as Research and Development advisor. Mr. Eggers has 30 years of experience in the development and marketing of medical devices. He is the VP of R&D for Zevex, a $100 million medical device company. During his four-year tenure, sales more than tripled and the company’s market value increased fourfold, culminating in an acquisition by Moog Medical Devices. Prior to joining Zevex, Mr. Eggers was the VP of R&D of CardioNet, a startup company, which pioneered mobile cardiac outpatient telemetry. CardioNet recently went public and has a market value over $500 million. Prior to CardioNet, Mr. Eggers held various senior- level positions in organizations including Alaris Medical Systems, Critikon, and Berkley BioEngineering. Mr. Eggers received a BA in Physics from the University of Colorado and an MBA from the University of Santa Clara.

Thermimage Inc was founded in February 2007 to commercialize a non-invasive, painless and less costly way to produce deep-tissue temperature measurements. The device will first be used to diagnose Vesicoureteral Reflux (VUR) in children, a dangerous condition that allows urine to backflow into the kidneys of young children. The current procedure is painful and requires the use of catheters and ionizing radiation, where this new technique will heat the contents of the bladder and then detect any increase in temperature in the kidneys signaling reflux.